SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The $SLAP crypto meme coin is trending with community members actively promoting the project. Discussions center around its meme-centric nature, real-world partnerships, and active community. Bullish sentiment seems to be building, with many users expressing excitement.

Aster is a next-generation decentralized exchange offering both Perpetual and Spot trading, designed as a one-stop onchain venue for global crypto traders. It features MEV-free, one-click execution in Simple Mode. Pro Mode adds 24/7 stock perpetuals, Hidden Orders, and grid trading, available across BNB Chain, Ethereum, Solana, and Arbitrum.  Its unique edge lies in the ability to offer liquid-staking tokens (asBNB) or yield-generating stablecoins (USDF) as collateral, unlocking unparalleled capital efficiency. Powered by Aster Chain, a high-performance and privacy-focused L1, and backed by YZi Labs, Aster is building the future of DeFi: fast, flexible, and community-first.  At the heart of this ecosystem is the $ASTER token, a core asset that decentralizes governance, drives growth, rewards participation, and supports long-term sustainability.

ASTERION

ASTERION (ASTER) is trending amid discussions about its potential and comparisons to other crypto assets. Community members are focused on CZ's involvement and the potential impact on ASTER's value, as well as speculation around future price movements and listings. The project is being discussed in the context of decentralized exchanges (DEXs) and the broader cryptocurrency market.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

ICP is trending amid discussions about its underlying technology and potential for future growth, especially regarding AI integration and decentralized web services. Community members are debating its long-term value, with some highlighting its unique features while others express concern over price performance and tokenomics. Recent discussions also touch on Bitcoin's ecosystem building on ICP and anticipation for the Caffeine AI release.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

$UUP is trending amidst fluctuating dollar strength influenced by factors like potential Fed rate cuts, global economic uncertainties, and U.S. government policies. Community discussions revolve around the interplay between the dollar, precious metals like gold, and potential shifts in currency valuations. Traders are closely watching economic data releases and central bank decisions for directional cues.

MUSE

$MUSE is trending as traders discuss its potential for significant gains, citing its low market cap and history of past pumps. Community members are closely watching volume and chart patterns, speculating on a possible breakout and the start of altcoin season. Some are comparing it to other low-cap coins that have experienced rapid growth.

Galaxy Digital Holdings Ltd.

Galaxy Digital is trending as anticipation builds for its upcoming Nasdaq listing, expected to broaden investor access and increase visibility. Community discussions focus on the potential for significant price appreciation, drawing comparisons to other crypto-related stocks, and the company's expansion into AI data centers is also a key talking point.

Common is the coordination layer for communities, contributors, and AI agents. It is an all-in-one product and protocol to launch a token, manage a DAO, or coordinate with agents.

Common

Common Crypto is trending as traders anticipate a potential breakout, with the community focused on key price levels. Optimism is fueled by expectations of a rapid price increase, as traders actively discuss entry points and potential short-term gains. The crypto's established base is also a frequently discussed factor.

Brookfield Asset Management Ltd. engages in the provision of alternative asset management services across renewable power and transition, infrastructure, private equity, real estate, and credit industry. It invests client capital for the long term with a focus on real assets and essential service businesses. The company was founded on July 4, 2022, and is headquartered in New York, NY.

Brookfield Asset Management Ltd - Ordinary Shares - Class A

Brookfield Asset Management Inc. - Ordinary Shares - Class A

Brookfield Asset Management is trending amid news of strategic partnerships and significant investments in nuclear energy and AI infrastructure, driving community discussion around its growth prospects and comparison to Berkshire Hathaway. Recent deals, including potential acquisitions and partnerships with Cameco and the U.S. government for nuclear reactor deployment, highlight Brookfield's focus on expanding into data centers and AI-related energy infrastructure. Investors are also weighing the implications of Brookfield's spin-off from Brookfield Corporation, analyzing the value of each entity and debating which offers more compelling long-term potential.

What is DigiByte? DigiByte is more than a faster digital currency. It is an innovative blockchain that can be used for digital assets, smart contracts, decentralized applications and secure authentication.   What makes DigiByte stronger than others? DigiByte is a rapidly growing open-source blockchain created in late 2013 and released in early 2014. After 6 years of forward thinking development, DigiByte has become one of the safest, fastest, longest and most decentralized UTXO blockchain in existence.   Truly Decentralized. DigiByte has never been funded through an ICO or significant amount of premined coins. There is no CEO or a company controlling the DigiByte blockchain. It is a volunteer based and global community driven project.   More secure. DigiByte uses 5 cryptographic algorithms and real time difficulty adjustment to prevent malicious mining centralization and hash power fluctuation. One of which is Odocrypt that changes itself every 10 days for ASIC resistance.   Much faster. DigiByte blocks occur every 15 seconds which is 40x faster than Bitcoin and 10x faster than Litecoin. Early SegWit implementation and blockchain rigidity enable up to 1066 on-chain transactions per second with negligible fees.   Forward thinking. Over the past 6 years, DigiByte has repeatedly set itself apart with multiple blockchain firsts, such asDigiShield guard, MultiAlgo mining, SegWit implementation, Odocrypt algorithm, Dandelion++ privacy protocol, DigiAssets and Digi-ID.       This is how the DigiByte blockchain works. The three layers are the most innovative parts of the DigiByte blockchain providing the network infrastructure, security and communications to function with cutting edge speed.    Applications / DigiAssets. The top layer is like an app store with clear real-world uses. All types of digital assets can be created with the DigiAssets protocol on top of the DigiByte blockchain. Decentralized applications (dApps) can be built on top of the DigiByte blockchain. Also smart contracts that leverage the rigidity and security of the DigiByte blockchain can be encoded easily.   Digital asset / Public ledger. The middle layer provides security and administration. A Digital Byte of data, a representation of larger data or a unit that holds value, and cannot be counterfeited, duplicated or hacked. An immutable public ledger where all transactions of DigiBytes are recorded. DigiByte uses five proof of work algorithms for security. New DigiBytes come from mining only.   Core protocol / Global network. The bottom layer provides communication and operating procedures. A very low-level way nodes on the DigiByte global network communicate. Thousands of people are running DigiByte software all across the planet. Any server, computer, tablet or mobile phone connected to the DigiByte network becomes a node that helps relay transactions.    Open source / Permissionless. Just like the DigiByte.io website, the DigiByte blockchain is completely open source and free to use released under the MIT license, which gives you the power to run and modify the software. Transparency allows for independent verification of binaries and their corresponding source code.        A digital currency you would absolutely love. DigiByte (DGB) is a highly scalable peer-to-peer digital currency that enables industry-leading transaction speeds with negligible fees. DigiByte is the best way for payments.   Easy to use. Getting started to use DigiByte is even easier than sending an SMS. You can send and receive DigiBytes using the devices you already know and love. All you need is installing a DigiByte supported wallet then click scan, scan the QR code and send DigiByte. As easy as 1..2..3.   Not an ICO. DigiByte has never been funded through an ICO or significant amount of premined coins (0% remaining). There is no CEO or a company controlling the DigiByte blockchain. The founder, developers and the community are unpaid volunteers that eliminate the bankrupt risk.   Much faster. DigiByte transactions are confirmed in approx. 15 seconds, which is 40 times faster than Bitcoin and 10 times faster than Litecoin. SegWit enables up to 1066 on-chain transactions per second and negligible fees make DigiByte the ideal currency for daily payments.    Always secure. DigiByte has been built on the uncrackable technology of the Bitcoin blockchain and implemented various advanced enhancements over it such as DigiShield guard, MultiAlgo mining and the Odocrypt algorithm. Also Dandelion++ privacy protocol helps keep you safe by hiding your IP and physical location. Learn more.   Mineable. DigiByte is a 100% Proof of Work (PoW) blockchain that can be mined with five algorithms called Sha256, Scrypt, Skein, Qubit and Odocrypt. MultiAlgo mining contributes to decentralization, security of the network and gives you the freedom to use different kind of hardware's such as an ASIC a FPGA or a GPU. Learn more.   Manageable units Compared to 21 million Bitcoin, 21 billion DigiByte (1000:1 ratio to BTC) have been designed to be ready for mass adoption. DigiByte block rewards reduces by 1% every month instead of halving every 4 years. All 21 billion DigiByte will be mined by the year 2035. After 2035 the miners will then rely on transaction fees alone. Learn more.     A simplified way to create digital assets. DigiAssets is a secure, scalable layer on top of the DigiByte blockchain that allows for the decentralized issuance of assets, tokens, smart contracts, digital identity and more.   Limitless possibilities. DigiAssets can be used to securely represent anything we find in the physical world. From tangible assets such as real estate or cars, through to scarce digital pieces of art. Signed documents such as deeds and medical bills can be protected.   Growing confidently. DigiAssets as an ecosystem and platform already has interested parties either planning on or currently building platforms in real estate, finance, remittance, identity, point of sale, racing, trade, healthcare, supply chain, government and more.   Solid technology. DigiAssets leverages unique aspects of a truly decentralized blockchain only found within a permissionless blockchain like DigiByte. This allows DigiAssets to be more secure, scalable and decentralized than any other platform in the market.      Authentication at its best. Digi-ID is a security protocol built on DigiByte blockchain technology that empowers users to effortlessly sign-in to websites, applications, and even into the internet of things.    Easy authentication. Digi-ID eliminates the username, password and 2fa requirements for authentication. Because Digi-ID uses public / private key cryptography, there are no passwords or usernames at risk. This method not only protects the consumer, it also protects the services that the consumer uses.    Flawless security. Digi-ID does not store any data about its users on the DigiByte blockchain. This further strengthens the security while also bolstering end-user’s confidence that their data is neither tracked nor at risk by others negligence. There is no external point of failure for an hacker to exploit your platform.   Simple and free. Digi-ID is completely free! There are no fees, subscription services, or maintenance costs. But the cost is its second best feature. Its primary feature is that, in accordance with DigiBytes security prioritization, Digi-ID is a more secure, yet simple method available to log in to websites, apps and more.     The most passionate community ever! Tens of thousands of volunteers from all over the world have contributed to DigiByte in countless ways for years to make it what it is today. It is a truly grassroots movement. We warmly welcome you to join us!   DigiByte Foundation. The DigiByte Foundation is a volunteer managed organization that operates in a non-profit way. They protect and promote the true principles of decentralization and empower DigiByte and its community to establish and maintain a sustainable decentralized world. Learn more.    DigiByte Awareness Team.  DGBAT is a community-driven outreach initiative. They are led by a team, whose members in turn manage teams across social media, outreach, education, writers and developers. They aim to promote the DigiByte blockchain through education, outreach and marketing campaigns. Learn more.    DigiByte Developers.  Everyone that is working on the DigiByte blockchain is an unpaid volunteer who devoted their time and skills to a project they believe in. Start contributing to the DGB development today or build your own app on top of the DigiByte blockchain. DigiByte Protocol on GitHub. DigiByte Core Development on GitHub.   The DigiByte Wiki. The DigiByte Wiki is an online encyclopedia built by the community, for the community. It contains useful and up to date data such as the DigiByte Ecosystem and how to guides. Anyone can positively contribute to the Wiki by creating a free user account and start adding or updating information on the DigiByte Wiki.    Meet the creator of DigiByte. Jared Tate is the founder and creator of the DigiByte blockchain. Jared dedicated full-time development towards DigiByte since October 2013. He has been invited by MIT, Harvard and the US Capitol to speak on blockchain tech. He is also the author of the book Blockchain 2035 The Digital DNA of Internet 3.0, which is the first book written by a blockchain founder.

DigiByte

DigiByte is trending as community members discuss its potential for a significant price increase, drawing comparisons to past market cycles. Some express frustration with its performance, while others highlight its strong fundamentals and upcoming Taproot activation, suggesting it's undervalued and ready for a breakout. Discussion includes speculation about the launch of a Digidollar stablecoin on the DGB blockchain.

Solaris Energy Infrastructure, Inc. is a holding company, which engages in the manufacture of patented mobile proppant management systems that unload, store, and deliver proppant to oil and natural gas well sites. Its products include Mobile Proppant and Mobile Chemical Management Systems, and Inventory Management Software. The firm's services include field, last mile management, and transloading services. The company was founded by William A. Zartler in 2014 and is headquartered in Houston, TX.

Solaris Energy Infrastructure Inc. - Ordinary Shares - Class A

Solaris Energy Infrastructure is trending due to its joint venture with xAI to power AI data centers, sparking community interest. Positive financial metrics, insider buying, and analyst upgrades also contribute to investor optimism around SEI. Community members are eyeing potential pullbacks as buying opportunities, while also assessing risks related to upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy?

Protagonist Therapeutics (PTGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates

Regeneron (REGN) delivered earnings and revenue surprises of +25.32% and +4.38%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Johnson &amp; Johnson’s (J&amp;J) stock&nbsp;fell 0.4% in premarket trade on Tuesday as investors positioned ahead of the healthcare giant’s quarterly results due Tuesday, with focus on its medical devices business, drug pipeline, and tariff exposure.The company is expected to post revenue of $23.76 billion, nearly flat from last year's $23.74 billion, according to estimates from Koyfin. Adjusted EPS is expected to be $2.76, down from $2.77 a year ago. EBITDA is expected to come in 0.6% lower at $8.58 billion, while EBIT is expected to tick up 0.5% to $8 billion.J&amp;J shares trade near $190.90, close to their 12-month average price target of $187.49, implying limited near-term upside. Analysts maintain a broadly positive stance, with 10 rating it a ‘Buy,’ 11 a ‘Hold,’ and two a ‘Strong Buy.’In July, J&amp;J cut its tariff-related cost forecast for the year to $200 million, down from $400 million, citing lower-than-expected impact on its medical devices business after the Trump administration paused some China and EU duties. CFO Joe Wolk said the company absorbed the costs while still raising its profit outlook, describing the tariff effect as “minimal.”Growth in the medtech unit is expected to be a bright spot, driven by sales from cardiovascular products such as Varipulse and Trupulse, and Abiomed’s Impella heart pumps. J&amp;J said in July that robotic surgery and cardiovascular devices will be the key engines of growth for its medtech unit.Attention will also be on Carvykti, J&amp;J’s blood cancer therapy developed with Legend Biotech, which recently received a U.S. FDA label update adding a black box warning for a rare intestinal inflammation. Regulators said the therapy’s benefits still outweigh risks, highlighting longer patient survival versus standard treatments.In immunology, the company faces renewed pressure from biosimilar competition to its top-selling drug Stelara. To offset potential declines, J&amp;J has been pursuing acquisitions, including reported talks to acquire Protagonist Therapeutics, its partner on an oral therapy for plaque psoriasis and ulcerative colitis. A deal would add late-stage drug Rusfertide, seen as complementary to J&amp;J’s immunology and oncology portfolios.Legal overhangs persist after a $966 million jury verdict in California earlier this month tied to talc-related cancer claims, which J&amp;J plans to appeal. The company maintains&nbsp;that its products are safe and asbestos-free.On Stocktwits, retail sentiment for J&amp;J was ‘extremely bullish’ amid a&nbsp; 2,200% surge in 24-hour message volume.One user predicted that J&amp;J shares could climb to the $196–$200 range after earnings, while others speculated the biotech might announce an Altimmune acquisition during Tuesday’s earnings call.<stembedurl>https://stocktwits.com/Wenwenwenwenwenwen/message/632192878</stembedurl><stembedurl>https://stocktwits.com/Ad7777/message/632156784</stembedurl><stembedurl>https://stocktwits.com/namv/message/632137184</stembedurl><a href="https://stocktwits.com/symbol/JNJ">J&amp;J’s stock</a> has risen 35% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

JNJ beat third-quarter earnings estimates but lowered guidance for the year 

Johnson & Johnson Stock Falls Premarket: Investors Eye MedTech Growth, Tariff Impact And Drug Pipeline In Q3 Print

Investors may also look for updates on J&J’s reported talks to acquire Protagonist Therapeutics to bolster its immunology and oncology pipeline.

Equity

BMO Capital raised its price target on Protagonist Therapeutics to $112 from $72 and maintained an 'Outperform' rating, citing reports that Johnson &amp; Johnson may acquire the biotech firm.&nbsp;In a note to investors, the firm said its updated model better reflects the potential value of Protagonist’s two key drug assets, Rusfertide and Icotrokinra, for an acquirer, and that the market is “underpricing what Protagonist could be worth.”<a href="https://stocktwits.com/symbol/PTGX">Protagonist Therapeutics’ stock</a> fell 9% to $79.17 on Monday, marking its worst trading session in more than three months, before edging up 0.1% in after-hours trade.J&amp;J is reportedly in talks to buy Protagonist in a deal that would strengthen its existing partnership on an oral therapy for immune diseases such as plaque psoriasis and ulcerative colitis, for which J&amp;J already holds exclusive commercialization rights. The healthcare giant also owns nearly 4% of Protagonist’s shares, The Wall Street Journal&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/pharma/johnson-johnson-in-talks-to-buy-protagonist-therapeutics-38e0b69d">reported</a> last week.An acquisition would give J&amp;J access to Rusfertide, which has shown promise in late-stage trials for polycythemia vera, a rare blood cancer. Both Rusfertide and Icotrokinra would complement J&amp;J’s existing portfolio of immune and oncology treatments.Meanwhile, J&amp;J is seeking acquisitions to offset declining sales of its blockbuster immune-disease drug Stelara, now facing biosimilar competition.On Stocktwits, retail sentiment was ‘bullish’ for Protagonist Therapeutics with ‘extremely high’ message volume, while sentiment toward Johnson &amp; Johnson was ‘extremely bullish’ amid normal activity.One user called the pullback in Protagonist a “great buying opportunity,” arguing that retail investors were mistaken to think the company would sell for less than $5 billion.&nbsp;<stembedurl>https://stocktwits.com/outlawinvestor1/message/632143522</stembedurl>On the other hand, another user predicted the potential deal could value Protagonist shares&nbsp;at around $35.<stembedurl>https://stocktwits.com/Fugazi_/message/632134508</stembedurl>So far this year, Protagonist shares have more than doubled in value, while&nbsp;<a href="https://stocktwits.com/symbol/JNJ">Johnson &amp; Johnson shares</a> have gained about 35%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

So far this year, Protagonist shares (PTGX) have more than doubled in value, while Johnson & Johnson shares (JNJ) have gained about 35%. (Photo credit: Getty Images)

BMO Capital Lifts Protagonist Therapeutics Target On J&J Deal Hopes — Retail Traders Pile In

The research firm said its higher target better reflects the value of Protagonist’s key drug assets, Rusfertide and Icotrokinra.

Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal

PTGX shares jump 30% after reports that J&J is in talks to acquire the biotech firm amid ongoing negotiations.

RTW Investments' Rod Wong: Expect more deals in biotech space

Rod Wong, RTW Investments CIO & Managing Director, joins CNBC's 'Money Movers' to discuss J&J's reported interest in buying Protagonist Therapeutics, whether he expects more consolidation in the...

JNJ Seeks EU Approval for Oral Psoriasis Drug Icotrokinra

J&J seeks EMA's nod to icotrokinra for treating plaque psoriasis in adults and pediatric patients aged 12 years and older.

Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates

Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of -3.77% and -46.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque psoriasis.

Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last?

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.64	--	--	N/A
Q2 '25	-$0.53	-$0.55	-4.10%	MISSED
Q1 '25	-$0.19	--	--	N/A
Q4 '24	$1.64	$1.98	20.78%	BEAT
Q3 '24	-$0.56	-$0.54	3.31%	BEAT

PTGX
Protagonist Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest PTGX News

PTGXProtagonist Therapeutics Inc